Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)

David M. PariserDepartment of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA;

Eric L. SimpsonDepartment of Dermatology, Oregon Health and Science University, Portland, OR, USA;

Abhijit GadkariHealth Economics and Outcomes Research, Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA;

Thomas BieberDepartment of Dermatology and Allergy, University Hospital Bonn, Bonn, Germany;

David J. MargolisDepartment of Dermatology, University of Pennsylvania Medical Center, Philadelphia, PA, USA;

Michelle BrownRTI Health Solutions, Research Triangle Park, NC, USA;

Lauren NelsonRTI Health Solutions, Research Triangle Park, NC, USA;

Puneet MahajanHealth Economics Value Assessment, Sanofi, Bridgewater, NJ, USA;

Matthew ReaneyFormerly, Health Economics and Outcomes Research, Sanofi, Guildford, UK;

Isabelle GuilleminHealth Economics Value Assessment, Sanofi, Chilly Mazarin, France;

Usha G. MallyaHealth Economics Value Assessment, Sanofi Genzyme, Cambridge, MA, USA

Laurent EckertHealth Economics Value Assessment, Sanofi, Chilly Mazarin, France; Correspondence[email protected]

Related Research Data